{"entity":{"type":"insider","cik":"0001655016","url":"/insider/0001655016","json_url":"/insider/0001655016.json","name":"Fox Jonathan C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":24,"first":"2015-11-05","last":"2025-11-13","span_basis":"filed_date"},"name_variants":[{"name":"Fox Jonathan C","source":"filing","n_filings":24,"first_seen":"2015-11-05","last_seen":"2025-11-13"}],"transactions":[{"id":4184213,"accession":"0001655016-25-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001655016-25-000007","line_url":"/filing/0001655016-25-000007#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10700.0,"shares_display":"10,700","price_per_share":18.6358,"price_display":"18.64","price_state":"stated","total_value":199403.06,"total_display":"199,403.06","total_whole":"199,403","shares_owned_after":23702.0,"shares_owned_after_display":"23,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-11","filed_date":"2025-11-13","scope":"insider"},{"id":7934357,"accession":"0001562180-23-008573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-008573","line_url":"/filing/0001562180-23-008573#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10857.0,"shares_display":"10,857","price_per_share":9.2989,"price_display":"9.30","price_state":"stated","total_value":100958.1573,"total_display":"100,958.16","total_whole":"100,958","shares_owned_after":10857.0,"shares_owned_after_display":"10,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-28","scope":"insider"},{"id":2169465,"accession":"0000899243-20-025694","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-025694","line_url":"/filing/0000899243-20-025694#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5767.0,"shares_display":"5,767","price_per_share":50.1576,"price_display":"50.16","price_state":"stated","total_value":289258.8792,"total_display":"289,258.88","total_whole":"289,259","shares_owned_after":377673.0,"shares_owned_after_display":"377,673","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-17","filed_date":"2020-09-18","scope":"insider"},{"id":2552914,"accession":"0000899243-20-025364","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-025364","line_url":"/filing/0000899243-20-025364#line-3","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3122.0,"shares_display":"3,122","price_per_share":50.1632,"price_display":"50.16","price_state":"stated","total_value":156609.5104,"total_display":"156,609.51","total_whole":"156,610","shares_owned_after":383440.0,"shares_owned_after_display":"383,440","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-16","filed_date":"2020-09-16","scope":"insider"},{"id":2552907,"accession":"0000899243-20-025364","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-025364","line_url":"/filing/0000899243-20-025364#line-2","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":50.064,"price_display":"50.06","price_state":"stated","total_value":50064.0,"total_display":"50,064.00","total_whole":"50,064","shares_owned_after":386562.0,"shares_owned_after_display":"386,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-15","filed_date":"2020-09-16","scope":"insider"},{"id":2552901,"accession":"0000899243-20-025364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-025364","line_url":"/filing/0000899243-20-025364#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":111.0,"shares_display":"111","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":5550.0,"total_display":"5,550.00","total_whole":"5,550","shares_owned_after":387562.0,"shares_owned_after_display":"387,562","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2020-09-16","scope":"insider"},{"id":2287647,"accession":"0000899243-20-018813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-018813","line_url":"/filing/0000899243-20-018813#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":387673.0,"shares_owned_after_display":"387,673","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-07","filed_date":"2020-07-09","scope":"insider"},{"id":2132827,"accession":"0000899243-20-015413","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-015413","line_url":"/filing/0000899243-20-015413#line-4","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":391585.0,"shares_owned_after_display":"391,585","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-05","scope":"insider"},{"id":2456075,"accession":"0000899243-20-014714","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-014714","line_url":"/filing/0000899243-20-014714#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":398625.0,"shares_owned_after_display":"398,625","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-28","filed_date":"2020-06-01","scope":"insider"},{"id":2100704,"accession":"0000899243-20-011341","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-011341","line_url":"/filing/0000899243-20-011341#line-2","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2153.0,"shares_display":"2,153","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":107650.0,"total_display":"107,650.00","total_whole":"107,650","shares_owned_after":403625.0,"shares_owned_after_display":"403,625","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-24","filed_date":"2020-04-27","scope":"insider"},{"id":2100701,"accession":"0000899243-20-011341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-011341","line_url":"/filing/0000899243-20-011341#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2847.0,"shares_display":"2,847","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":142350.0,"total_display":"142,350.00","total_whole":"142,350","shares_owned_after":405778.0,"shares_owned_after_display":"405,778","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-23","filed_date":"2020-04-27","scope":"insider"},{"id":2281858,"accession":"0000899243-20-006941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-006941","line_url":"/filing/0000899243-20-006941#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":51.5706,"price_display":"51.57","price_state":"stated","total_value":515706.0,"total_display":"515,706.00","total_whole":"515,706","shares_owned_after":408625.0,"shares_owned_after_display":"408,625","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider"},{"id":2725445,"accession":"0000899243-20-005000","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-005000","line_url":"/filing/0000899243-20-005000#line-2","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":54.0,"price_display":"54.00","price_state":"stated","total_value":540000.0,"total_display":"540,000.00","total_whole":"540,000","shares_owned_after":418625.0,"shares_owned_after_display":"418,625","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-19","scope":"insider"},{"id":2417733,"accession":"0000899243-20-001337","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-001337","line_url":"/filing/0000899243-20-001337#line-2","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3580.0,"shares_display":"3,580","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":196900.0,"total_display":"196,900.00","total_whole":"196,900","shares_owned_after":430257.0,"shares_owned_after_display":"430,257","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-15","filed_date":"2020-01-16","scope":"insider"},{"id":2417730,"accession":"0000899243-20-001337","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-001337","line_url":"/filing/0000899243-20-001337#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6420.0,"shares_display":"6,420","price_per_share":55.0112,"price_display":"55.01","price_state":"stated","total_value":353171.904,"total_display":"353,171.90","total_whole":"353,172","shares_owned_after":433837.0,"shares_owned_after_display":"433,837","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-14","filed_date":"2020-01-16","scope":"insider"},{"id":7775905,"accession":"0000899243-19-028617","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-028617","line_url":"/filing/0000899243-19-028617#line-2","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":58.9048,"price_display":"58.90","price_state":"stated","total_value":589048.0,"total_display":"589,048.00","total_whole":"589,048","shares_owned_after":440527.0,"shares_owned_after_display":"440,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-04","filed_date":"2019-12-05","scope":"insider"},{"id":8091928,"accession":"0000899243-19-028274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-028274","line_url":"/filing/0000899243-19-028274#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":56.5218,"price_display":"56.52","price_state":"stated","total_value":565218.0,"total_display":"565,218.00","total_whole":"565,218","shares_owned_after":451527.0,"shares_owned_after_display":"451,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-25","filed_date":"2019-11-27","scope":"insider"},{"id":7831339,"accession":"0000899243-19-028028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-028028","line_url":"/filing/0000899243-19-028028#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.1073,"price_display":"55.11","price_state":"stated","total_value":551073.0,"total_display":"551,073.00","total_whole":"551,073","shares_owned_after":461527.0,"shares_owned_after_display":"461,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-21","filed_date":"2019-11-22","scope":"insider"},{"id":8696632,"accession":"0000899243-19-027574","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-027574","line_url":"/filing/0000899243-19-027574#line-4","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.2574,"price_display":"50.26","price_state":"stated","total_value":502574.0,"total_display":"502,574.00","total_whole":"502,574","shares_owned_after":471527.0,"shares_owned_after_display":"471,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-19","scope":"insider"},{"id":8696629,"accession":"0000899243-19-027574","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-027574","line_url":"/filing/0000899243-19-027574","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":45.425884,"price_display":"45.43","price_state":"stated","total_value":227129.42,"total_display":"227,129.42","total_whole":"227,129","shares_owned_after":482427.0,"shares_owned_after_display":"482,427","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-15","filed_date":"2019-11-19","scope":"insider","n_lines":3},{"id":8472332,"accession":"0000899243-19-025615","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-025615","line_url":"/filing/0000899243-19-025615","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":36.16351868,"price_display":"36.16","price_state":"stated","total_value":180817.5934,"total_display":"180,817.59","total_whole":"180,818","shares_owned_after":486529.0,"shares_owned_after_display":"486,529","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-15","filed_date":"2019-10-16","scope":"insider","n_lines":2},{"id":8472210,"accession":"0000899243-19-023815","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-023815","line_url":"/filing/0000899243-19-023815#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":45.7444,"price_display":"45.74","price_state":"stated","total_value":228722.0,"total_display":"228,722.00","total_whole":"228,722","shares_owned_after":491527.0,"shares_owned_after_display":"491,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-16","filed_date":"2019-09-18","scope":"insider"},{"id":8472092,"accession":"0000899243-19-022075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-022075","line_url":"/filing/0000899243-19-022075","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":38.719168,"price_display":"38.72","price_state":"stated","total_value":193595.84,"total_display":"193,595.84","total_whole":"193,596","shares_owned_after":496527.0,"shares_owned_after_display":"496,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-19","scope":"insider","n_lines":2},{"id":7886345,"accession":"0000899243-19-019765","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-019765","line_url":"/filing/0000899243-19-019765#line-2","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":40.0374,"price_display":"40.04","price_state":"stated","total_value":600561.0,"total_display":"600,561.00","total_whole":"600,561","shares_owned_after":501527.0,"shares_owned_after_display":"501,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-15","filed_date":"2019-07-17","scope":"insider"},{"id":8022151,"accession":"0000899243-19-015285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-015285","line_url":"/filing/0000899243-19-015285#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.6357,"price_display":"32.64","price_state":"stated","total_value":163178.5,"total_display":"163,178.50","total_whole":"163,179","shares_owned_after":516527.0,"shares_owned_after_display":"516,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-30","filed_date":"2019-05-31","scope":"insider"},{"id":8143603,"accession":"0000899243-19-012357","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-012357","line_url":"/filing/0000899243-19-012357#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.03,"price_display":"25.03","price_state":"stated","total_value":125150.0,"total_display":"125,150.00","total_whole":"125,150","shares_owned_after":521527.0,"shares_owned_after_display":"521,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-03","filed_date":"2019-05-06","scope":"insider"},{"id":8633923,"accession":"0000899243-19-012105","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-012105","line_url":"/filing/0000899243-19-012105","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.457336,"price_display":"25.46","price_state":"stated","total_value":127286.68,"total_display":"127,286.68","total_whole":"127,287","shares_owned_after":526527.0,"shares_owned_after_display":"526,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-01","filed_date":"2019-05-03","scope":"insider","n_lines":2},{"id":8580673,"accession":"0000899243-19-010707","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-010707","line_url":"/filing/0000899243-19-010707#line-1","is_derivative":false,"issuer_cik":"0001655016","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001655016","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":23.11,"price_display":"23.11","price_state":"stated","total_value":115550.0,"total_display":"115,550.00","total_whole":"115,550","shares_owned_after":531527.0,"shares_owned_after_display":"531,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-04-15","filed_date":"2019-04-16","scope":"insider"},{"id":8683350,"accession":"0000899243-15-007675","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-007675","line_url":"/filing/0000899243-15-007675#line-1","is_derivative":false,"issuer_cik":"0001552451","issuer_name":"MyoKardia Inc","issuer_ticker":"MYOK","issuer_name_source":null,"issuer_url":"/issuer/0001552451","owner_cik":"0001655016","owner_name":"Fox Jonathan C","owner_display_name":"Fox Jonathan C","owner_url":"/insider/0001655016","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":239190.0,"shares_owned_after_display":"239,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-03","filed_date":"2015-11-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":34,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":34},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001710072","name":"Edgewise Therapeutics, Inc.","url":"/issuer/0001710072","role":"Director","n_filings":2,"first_seen":"2023-12-28","last_seen":"2025-11-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001731831","name":"Eidos Therapeutics, Inc.","url":"/issuer/0001731831","role":"Officer","n_filings":21,"first_seen":"2019-04-16","last_seen":"2020-09-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001552451","name":"MyoKardia Inc","url":"/issuer/0001552451","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2015-11-05","last_seen":"2015-11-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001655016","retrieved_at":"2026-08-23T05:28:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}